Biodesix Inc (BDSX): Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

Brandmark of Biodesix Corp (BDSX)

Biodesix, Inc. (BDSX) relies on its own laboratories while outsourcing cloud storage maintenance to external IT contractors. This chart of the market valuation with a coefficient of 0.00 confirms the resilience of the model. Physician loyalty to proven lung cancer diagnostic methods guarantees a steady volume of orders. Meanwhile, the rapid growth in the number of specialized centers and high demand for rapid tests facilitate the expansion of the client network.

Biodesix Corp - BDSX EV/EBITDA Multiple (period 11/23/2025 - 11/12/2026)

BDSX (biodesix.com): analytical breakdowns and indicator data

- current price and projected stock value:
Stock Price Biodesix Corp|BDSX - Analyst Consensus Forecast
- stock exchange capitalization data:
Market Value Biodesix Corporation|BDSX - Business Value
- book value of equity indicators:
Book Value per Share Biodesix|BDSX - Book Capitalization|Market Value to Book Value Ratio biodesix.com|BDSX - Aggregate Company Assets
- company total debt and liquidity indicators:
Total Debt to Equity Ratio Biodesix, Inc.|BDSX - Long-Term Liabilities to Capital|Short-Term Debt to Equity Biodesix|BDSX - Company Total Debt Obligations|Debts to Book Capitalization Biodesix Corporation|BDSX - Long-Term Debt Volume|Company Short-Term Debt Biodesix|Quick Ratio biodesix.com
- financial results and valuation multiples details:
BDSX - Company Net Income|Projected Future Earnings Biodesix, Inc.|BDSX - Business Payback Period|Future Price to Earnings Biodesix, Inc.|BDSX - Price to Earnings Adjusted for Growth Rate|EV/EBITDA Multiple Biodesix Corporation|BDSX - Operating profit before amortization|Net earnings per share (EPS TTM) Biodesix|BDSX - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months biodesix.com|BDSX - Expected net earnings per share growth this year|Earnings growth forecast for next year Biodesix, Inc.
Comprehensive company analysis:Biodesix Corp BDSX
Manufactured products of Biodesix

For the non-invasive lung cancer diagnostics innovator Biodesix, Inc. (BDSX), an EV/EBITDA valuation allows for the correlation of the total business value, including debt, with its operational efficiency. The current value of 0.00 on the EV/EBITDA multiple chart reflects the market balance between capital expenditures on AI technologies and the company's actual ability to generate earnings before interest, taxes, depreciation, and amortization.

Analysis of competing companies

EV/EBITDA Multiple CAI (Caris)|EV/EBITDA Multiple Guardant Corp GH|VCYT - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|CELC (celcuity.com) - Enterprise Value to Operating Income Before Depreciation|GRAL: EV/EBITDA Multiple|Myriad Genetics Inc (MYGN) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Castle Biosciences Corp|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization BNR|Enterprise Value to EBITDA Ratio VNRX (VolitionRx Limited)|PRPO - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Check-Cap CHEK|Total Company Value to Operating Income Before Depreciation Ratio mainzbiomed.com (MYNZ)|OncoCyte Corp. - EV/EBITDA Multiple